MENU
SEPN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Septerna (SEPN) Ownership - Who owns Septerna?
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
453.16M
P/E Ratio
N/A
Total Cash
336.01M
Projected Growth
N/A
Total Debt
25.03M
Revenue
977K
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
7.54
Total Debt/Equity
N/A
Revenue/Share
0.02 USD as % of share price
Fundamentals
SEPN
Capitalization
453M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
336M
Total Cash/Share
7.54
Total Debt
25M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.02%
Revenue
977K
ROE
N/A
Book Value
400M
P/B Ratio
1.13
Cash Flow
N/A
Earnings
-1.78
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
44K
Current Ratio
32.19
Current Revenue Per Employee
2920.00
Dividends Per Share - Security
N/A
EBITDA
-89.76M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-18.23
Shares Held By Institutions
297M
Shares Outstanding - Current
44.6M
Total Liabilities
33.8M
Total Volume MTD
N/A
Value
-1
Gain YTD
-55.590
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information